Meggle Introduces New High-Functionality Excipient
CombiLac is a lactose-based, co-processed excipient, designed to ease oral solid dosage form development and manufacture in direct compression.
Excipient supplier, Meggle has launched a new high-functionality excipient, CombiLac, which consists of the spray-dried, ternary admixture of alpha-lactose monohydrate, microcrystalline cellulose, and starch, all conforming with Ph. Eur., USP-NF, and JP compendial requirements.
The excipient is designed for direct compression applications but can also be used in other formulation development approaches, such as dry granulation. The good powder flow characteristics enhance solid dosage form weight uniformity and throughput in tablet production.
CombiLac compliments the differentiated functionality of Meggle’s co-processed excipients portfolio. According to the company, a well-defined manufacturing process is used to create these porous, spherical particles with a highly integrated structure that is inseparable by physical means.
Because of the improved compaction properties compared with an equivalent blend of the individual ingredients, CombiLac enables the production of robust tablets with minimal friability. Rapid, hardness-independent tablet disintegration offering effective API release can be achieved. In production, release testing is reduced due to its ternary composition.
Source: Meggle
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
